Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development.
about
Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Selenium targets resistance bi ...... ical and clinical development.
@en
Selenium targets resistance bi ...... ical and clinical development.
@nl
type
label
Selenium targets resistance bi ...... ical and clinical development.
@en
Selenium targets resistance bi ...... ical and clinical development.
@nl
prefLabel
Selenium targets resistance bi ...... ical and clinical development.
@en
Selenium targets resistance bi ...... ical and clinical development.
@nl
P2860
P356
P1433
P1476
Selenium targets resistance bi ...... nical and clinical development
@en
P2093
Arup Bhattacharya
Youcef M Rustum
P2860
P304
10765-10783
P356
10.18632/ONCOTARGET.24297
P407
P577
2018-01-23T00:00:00Z